ArticleSurgical endoscopy2026
Robotic Ivor Lewis esophagectomy experience and outcomes from a high-volume cancer center with propensity-matched comparative assessment to the ACS-NSQIP database.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAdoption of minimally invasive techniques for esophagectomy has increased and has become preferred compared to open esophagectomy (OE). The purpose of this study is to report the experience of a high-volume cancer center compared to a contemporary OE series from the ACS-NSQIP database.
methodsSingle institution retrospective study from a prospective database of 1,448 patients undergoing esophagectomy. Included patients underwent elective robotic Ivor Lewis esophagectomy (RILE) for non-metastatic esophageal cancer. Patients were matched by demographic and oncologic preoperative characteristics and outcomes were compared to the 2016-2023 ACS-NSQIP esophagectomy targeted database.
resultsFrom 2010 to 2025, 649 robotic total esophagectomies were performed with 582 patients undergoing elective RILE. Patients were predominantly white males, 66 (IQR: 58-71) years old, BMI of 27.2 (24.2-30.8), ASA of 3, 466 patients received neoadjuvant chemotherapy, and 459 patients received radiation. Median operative time was 421 (IQR: 383-470) minutes, estimated blood loss was 150 (IQR: 100-250) mL, 23 (Range: 4-64) lymph nodes were harvested, and R0 resection was obtained 95.7%. One hundred eighty-nine patients were matched 1:1 to ACS-NSQIP OE control preoperative variables. Patients who underwent RILE had decreased serious morbidity (14.3% vs. 26.5%, p = 0.003), reoperation (2.6% vs. 14.3%, <0.001), pulmonary complications (12.2% vs. 22.2%, p = 0.010), and length of stay (9 vs. 10 days, p < 0.001). Operative time (415 vs. 323 min, p < 0.001) was longer in the RILE cohort. There was no difference in leak rate or 30-day mortality.
conclusionIn this large single institutional series of over 15 years of performing RILE, we report favorable perioperative outcomes compared to the contemporary national open esophagectomy cohort from the ACS-NSQIP database.
Indexed as
Identifiers
42745053What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.